已收盘 02-06 16:00:00 美东时间
+2.890
+4.32%
Nabors Industries (NYSE:NBR) said on Thursday that it has fully redeemed its 7.5% Senior Guaranteed Notes due 2028, with a face value of about $379M, at par plus accrued interest on Jan. 15, 2026. As ...
01-16 05:30
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
Susquehanna analyst Charles Minervino maintains Nabors Industries (NYSE:NBR) with a Neutral and raises the price target from $56 to $64.
01-08 01:33
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43
Barclays analyst Eddie Kim maintains Nabors Industries (NYSE:NBR) with a Underweight and raises the price target from $36 to $45.
2025-11-11 23:26
HAMILTON, Bermuda, Nov. 4, 2025 /PRNewswire/ -- Nabors Industries Ltd. ("Nabors" or the "Company") (NYSE: NBR) today commented on the recent credit ratings actions taken by all three of the ...
2025-11-05 07:41
HAMILTON, Bermuda, Nov. 4, 2025 /PRNewswire/ -- Nabors Industries Ltd. (NYSE: NBR) ("Nabors") today announced that Nabors Industries, Inc. ("NII") has priced $700 million in aggregate princi...
2025-11-05 07:35
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
2025-11-04 10:31